Dr. Daniel Friedrich

Angestellt, Head of Research & Development and LCM, B. Braun Group

Bad Homburg vor der Höhe, Deutschland

Fähigkeiten und Kenntnisse

Preclinical drug development
Pharmakologie
Project management
in vivo Pharmacology
Biochemistry
Drug development
Physiology
Biology
Formulation
in vitro Pharmacology
Protein biochemistry
small molecule drugs
Therapeutic peptides
CNS
Oncology
Metabolic diseases
Enzymology
Pharmacokinetics
Medical Engineering
Animal models
Outsourcing
External cooperation (CRO)
Biotechnologie
Toxicology
Safety Pharmacology
Parenteral Nutrition
Management
Forschung und Entwicklung
Innovationsmanagement
Biologics
Biowissenschaften
Führungserfahrung
Organisationstalent
Zuverlässigkeit
Interkulturelle Kompetenz
Flexibilität
Verantwortungsbewusstsein
Analytisches Denken
Vernetztes Denken
Zielstrebigkeit

Werdegang

Berufserfahrung von Daniel Friedrich

  • Bis heute 2 Jahre und 2 Monate, seit Apr. 2022

    Head of Research & Development and LCM

    B. Braun Group

  • Bis heute 5 Jahre und 2 Monate, seit Apr. 2019

    Director Global Preclinical Development

    Fresenius Kabi
  • 1 Jahr und 4 Monate, Dez. 2017 - März 2019

    Senior Preclinical Project Manager - Global Medical, Clinical & Regulatory Aff.

    Fresenius Kabi

    Global Medical, Clinical & Regulatory Affairs

  • 1 Jahr und 4 Monate, Aug. 2016 - Nov. 2017

    Preclinical Project Manager - Global Medical, Clinical & Regulatory Affairs

    Fresenius Kabi

    Global Medical, Clinical & Regulatory Affairs

  • 3 Jahre und 11 Monate, Sep. 2012 - Juli 2016

    Project Manager - Late Discovery & Preclinical Development

    Nexigen GmbH

    Project manager in early and late preclinical as well as early clinical development of peptide based therapeutics with focus on intracellular targets in the field of oncology. Responsibility for the coordination of internal and external cross-functional teams working on the advancement of innovative drugs candidates (CRO, Bioanalytics, ADME, PD, Safety and more). Project planning and scientific and regulatory realization from early development and target validation up to the early clinical trials.

  • 5 Jahre und 8 Monate, Jan. 2007 - Aug. 2012

    Director in vivo pharmacology

    Probiodrug AG

    Pre-Clinical Drug Development and Target validation in inflammatory and neurodegenerative disorders as well as metabolic diseases Pharmacokinetic and Pharmacodynamic in vivo and in vitro models Compound characterization, development and scoring

  • 2 Jahre und 6 Monate, Juli 2004 - Dez. 2006

    Project leader

    Probiodrug AG

    Project leader in the field of neurodegenerative and metabolic disorders Protein biochemistry, enzymoligy, biochemistry, molecular biology, cell culture and biotechnology Mentoring of technicians, diploma and bachelor students, student research assistants

  • 3 Jahre und 1 Monat, Juni 2001 - Juni 2004

    Scientist – Biochemistry, enzymology, molecular biology

    BioService Halle GmbH / Probiodrug AG

  • 1 Jahr und 4 Monate, März 2000 - Juni 2001

    Department of biochemistry and enzymology

    Probiodrug AG

  • 7 Monate, März 1999 - Sep. 1999

    Department of bioanalytics

    Probiodrug AG

Ausbildung von Daniel Friedrich

  • 2004 - 2006

    Biochemistry / Biotechnology

    Martin-Luther-Universität Halle-Wittenberg

    Protein biotechnology, Enzymology, Biotechnology, Molecular Biology, neurodegenerative and metabolic disorders ...

  • 1996 - 2001

    Biotechnology / Medical engineering

    University of applied science Jena

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

21 Mio. XING Mitglieder, von A bis Z